松木絵里

Matsuki Eri

論文 (26件)：

Matsuki E, Bohn OL, El Jamal S, Pichardo JD, Zelenetz AD, Younes A, Teruya-Feldstein J. Lymphocyte-to-Monocyte Ratio May Serve as a Better Prognostic Indicator Than Tumor-associated Macrophages in DLBCL Treated With Rituximab. Applied immunohistochemistry & molecular morphology : AIMM. 2018
Shoyo Shibata, Yusuke Wayama, Ai Tsuyuki, Maiko Matsushita, Koji Chiba, Eri Matsuki, Shinichiro Okamoto, Takeshi Suzuki. An Empirical Study of the Prescription Pattern of Drugs for Hematological Malignancies in Japan from 2010-2014. BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2017. 40. 6. 894-901
Eri Matsuki, Anas Younes. Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma. CURRENT TREATMENT OPTIONS IN ONCOLOGY. 2016. 17. 6. 31
Connie Lee Batlevi, Eri Matsuki, Renier J. Brentjens, Anas Younes. Novel immunotherapies in lymphoid malignancies. NATURE REVIEWS CLINICAL ONCOLOGY. 2016. 13. 1. 25-40
Eri Matsuki, Anas Younes. Lymphomagenesis in Hodgkin lymphoma. SEMINARS IN CANCER BIOLOGY. 2015. 34. 14-21

講演・口頭発表等 (54件)：

当院における骨髄異形成症候群,慢性骨髄単球性白血病に対するAzacitidine療法の検討
(臨床血液 2017)
Real-life use of bendamustine for B-cell non-Hodgkin lymphoma in a single institute
(臨床血液 2017)
骨髄増殖性疾患の経過中にEvans症候群を発症した1例
(臨床血液 2017)
Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients
(BLOOD 2016)
Association of MHC-II, PD-L1, and FoxP3 with Disease Status and Outcomes in Patients with Hodgkin Lymphoma
(BLOOD 2016)

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

松木 絵里